Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Jan / Case of the Month
Hematology Biochemistry and molecular biology Hematology

Case of the Month

01/11/2022 Quick Read (pre 2022) 1 min read

Share

A two-day-old boy of Nigerian descent was tested for hemoglobin disorders. His father was known to have sickle cell trait. The patient’s sickle cell solubility test was positive. His red cell indices, serum ferritin, and hemoglobin electrophoresis histogram by capillary electrophoresis are shown below: 

What is the best diagnosis for this newborn? 

a. Sickle cell trait (Hb AS)
b. Sickle cell anemia (Hb SS)
c. Sickle beta-plus thalassemia (Hb Sβ+ thalassemia) 
d. Sickle beta-zero thalassemia (Hb S/β0 thalassemia)

Click here to register your guess.

Do you have an interesting case that you would like us to feature? Email it to edit@thepathologist.com.

Answer to December's Case of the Month

Verrucous plaque with hemorrhagic crusting on the scalp.
H&E; 1x magnification.
H&E; 15x magnification.
H&E; 20x magnification.

C. Verrucous pseudonevoid melanoma

Histopathology revealed marked epidermal hyperplasia and papillomatosis overlying a broad, atypical melanocytic proliferation. Melanocytes were seen proliferating in a confluent fashion in both nests and solitary units at and above the dermo-epidermal junction. An uneven, sheet-like proliferation of small, uniform-appearing melanocytes was seen in the upper dermis. Melanocytes arranged in parallel cords – the so-called parallel thèque pattern (1) – with surrounding sclerosis were observed. Rare dermal mitoses were identified and Ki-67 stain (not shown) revealed a proliferation index of approximately 10–15 percent in the dermal melanocytes.

The overall presentation was most consistent with a verrucous pseudonevoid melanoma of the scalp. The Breslow depth was measured at 1 mm. The patient was treated with a wide local excision with 1 cm margins. The re-excision specimen showed focal residual melanoma in situ and clear margins. A sentinel lymph node biopsy was performed for additional prognostication and was found to be negative for metastatic disease, yielding a final stage of 1a.

Nevoid melanoma is a rare entity that presents significant diagnostic difficulty on both clinical and histopathological grounds (2,3,4,5). On physical examination, this tumor can be mistaken clinically for a verruca, benign melanocytic or epidermal nevus, or seborrheic keratosis. Two major architectural variants have been reported: verrucous subtype and a dome-shaped variant (resembling a Meissner or Spitz nevus). The verrucous subtype (as seen in this case) has the following features that may distinguish it from a papillomatous nevus: i) broad, exophytic growth pattern with verrucous epidermal hyperplasia, ii) continuous proliferation of melanocytes along the dermal-epidermal junction, iii) confluent sheets of small- to medium-sized melanocytes in the dermis without evidence of true maturation, and iv) low, but appreciable dermal mitotic activity.

Risk of mortality in nevoid melanoma is thought to be consistent with that of traditional melanomas of the same Breslow depth. Nevoid melanomas are often more advanced at the time of diagnosis given the propensity for initial clinical or histologic misdiagnosis. Heightened awareness of this entity is critical to promote earlier biopsy and avoidance of misdiagnosis (6).

Submitted by Rand Abou Shaar, Department of Pathology; Joseph McGoey, Department of Dermatology; and Ben J. Friedman, Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. MH Idriss et al., J Am Acad Dermatol, 73, 836 (2015). PMID: 26299955.
  2. TY Wong et al., Hum Pathol, 26, 171 (1995). PMID: 7860047.
  3. C Schmoeckel et al., Arch Dermatol Res, 277, 362 (1985). PMID: 4026378.
  4. A Zembowicz et al., Am J Dermatopathol, 23, 167 (2001). PMID: 11391094.
  5. K Blessing et al., Histopathology, 23, 453 (1993). PMID: 8314219.
  6. R Cabrera, F Recule, Am J Clin Dermatol, 19(Suppl 1), 15 (2018). PMID: 30374898.

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Biochemistry and molecular biology
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Biochemistry and molecular biology
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

qPCR Infectious Disease Detective
Biochemistry and molecular biology
qPCR: Infectious Disease Detective

January 4, 2024

3 min read

How quantitative polymerase chain reaction really hits the mark in epidemic control and ID detection

Case of the Month
Biochemistry and molecular biology
Case of the Month

January 11, 2022

1 min read

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.